Role of the Kallikrein-kinin System in Septic Cardiomyopathy

NCT06080282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 567

Last updated 2026-05-19

No results posted yet for this study

Summary

The purpose of this study is to investigate whether there are differential expressions of molecules in the kallikrein-kinin system (KKS) pathway in septic cardiomyopathy, and to analyze their regulatory mechanisms and gene expression changes.

Conditions

Sponsors & Collaborators

  • Qin Zhang

    lead OTHER

Principal Investigators

  • QIN Zhang, phd · Tongji Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2024-10-14
Completion
2024-10-14

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06080282 on ClinicalTrials.gov